| Product Name | ELIDEL CREAM 1% W/W |
| Active Ingredient (Strength) | Pimecrolimus(10 mg/g) |
| Product Registrant | PHARMLINE MARKETING PTE. LTD. |
| Date of Approval | 20/11/2023 |
| Indications: Elidel 1% cream is indicated for the short-term and intermittent long-term therapy in the treatment of mild to moderate atopic dermatitis in nonimmunocompromised patients 3 months of age and older, in whom the use of alternate, conventional therapies is deemed inadvisable because of the potential risks, or in the treatment of patients who are not adequately responsive to or intolerant of alternative, conventional therapies. | |
HSA: Health Sciences Authority
Link to the HSA announcement: https://www.hsa.gov.sg/announcements/new-drug-indication-approvals/new-drug-indication-approval—november-2023
Only Authentic Products and Genuine Medical Supplies, at POM Marketplace!
Login or Register now to access our comprehensive range of medical supplies.
Disclaimer: The information provided on this page is intended solely for healthcare professionals for informational purposes only. While we strive for accuracy, POMConnect assumes no liability for errors or omissions. The content here should not be considered a substitute for professional medical advice. POMConnect does not endorse specific treatments or external websites linked from this page. Please note that the information is accurate at the time of publication and does not account for any modifications or updates made to the original research article after its initial publish date. POM Marketplace is accessible to qualified healthcare professionals only. Any unauthorized access or use by individuals who do not meet this criteria is prohibited.
